HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kimberly A Risma Selected Research

Proteins (Proteins, Gene)

1/2019Hemophagocytic Lymphohistiocytosis: Clinical Presentations and Diagnosis.
1/2013Elevated Granzyme B in Cytotoxic Lymphocytes is a Signature of Immune Activation in Hemophagocytic Lymphohistiocytosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kimberly A Risma Research Topics

Disease

5Anaphylaxis (Anaphylactic Shock)
01/2023 - 01/2021
4COVID-19
04/2024 - 01/2021
4Hypersensitivity (Allergy)
01/2023 - 01/2021
4Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome)
04/2015 - 01/2006
1Infections
04/2024
1Anemia
04/2024
1Immediate Hypersensitivity
01/2023
1Angioedema
11/2022
1Urticaria (Hives)
11/2022
1Fever (Fevers)
11/2022
1Virus Diseases (Viral Diseases)
01/2022
1Respiratory Tract Infections (Respiratory Tract Infection)
01/2022
1Lymphoproliferative Disorders (Lymphoproliferative Disorder)
01/2019
1Neoplasms (Cancer)
08/2015
1Cytokine Release Syndrome
04/2015
1Cytopenia
04/2015
1Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome)
01/2010
12 X-Linked Lymphoproliferative Syndrome
09/2009
1Hypergammaglobulinemia (Hyperimmunoglobulinemia)
07/2007
1Autoimmune Diseases (Autoimmune Disease)
07/2007
1Alopecia (Baldness)
07/2007
1Eosinophilic Esophagitis
07/2007
1Carcinogenesis
01/2006
1Leukemia
01/2006
1Granuloma
07/2004
1Asthma (Bronchial Asthma)
08/2002

Drug/Important Bio-Agent (IBA)

4VaccinesIBA
04/2024 - 01/2021
4PerforinIBA
08/2015 - 01/2006
3Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric
01/2023 - 01/2021
3Messenger RNA (mRNA)IBA
01/2023 - 01/2021
3AntibodiesIBA
01/2023 - 09/2009
2COVID-19 VaccinesIBA
04/2024 - 01/2023
2Immunoglobulin E (IgE)IBA
01/2023 - 12/2021
2mRNA VaccinesIBA
12/2021 - 01/2021
2Proteins (Proteins, Gene)FDA Link
01/2019 - 01/2013
2Granzymes (Granzyme)IBA
08/2015 - 01/2013
1Amoxicillin (Wymox)FDA LinkGeneric
11/2022
1Adrenal Cortex Hormones (Corticosteroids)IBA
11/2022
1Immunoglobulins (Immunoglobulin)IBA
01/2022
1Interferon Type IIBA
01/2022
1PlacebosIBA
12/2021
1Vaccine ExcipientsIBA
12/2021
1Excipients (Suspending Agents)IBA
12/2021
1VancomycinFDA LinkGeneric
01/2021
1Nucleic AcidsIBA
01/2021
1Lipid NanoparticlesIBA
01/2021
1Complement System Proteins (Complement)IBA
01/2021
1PolymersIBA
01/2021
1AntigensIBA
01/2021
1NLR ProteinsIBA
01/2019
1Death Domain ReceptorsIBA
08/2015
1CytokinesIBA
04/2015
1Rotavirus VaccinesIBA
01/2010
1Rheumatoid FactorIBA
07/2007
1CC ChemokinesIBA
07/2007
1Chemokine CCL26IBA
07/2007
1Keratins (Keratin)IBA
07/2004
1Interleukin-4 Receptors (Interleukin 4 Receptor)IBA
08/2002

Therapy/Procedure

1Critical Care (Surgical Intensive Care)
04/2024
1Ambulatory Care (Outpatient Care)
11/2022
1Immunotherapy
01/2022
1Contraindications
12/2021
1Therapeutics
08/2015
1Cell Transplantation
09/2009